Rapid Micro Biosystems RPID Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$50.14M-6.4% | -$47.12M-6.4% | -$44.29M-0.4% | -$44.11M+1.6% | -$44.83M+4.4% | ||
| $3.11M-4.3% | $3.25M-2.4% | $3.33M-1.6% | $3.39M-0.5% | $3.4M+1.2% | ||
| $4.21M+4.5% | $4.03M-1.5% | $4.1M+5.6% | $3.88M+1.2% | $3.83M-1.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$400K-120% | ||
| -$2.68M-83.2% | -$1.47M— | —— | —— | —— | ||
| $2.03M+26.9% | $1.6M+27.4% | $1.26M+8.7% | $1.16M-21.5% | $1.47M+162% | ||
| —— | —— | —— | —— | —— | ||
| -$51K+20.3% | -$64K-740% | $10K-93.4% | $151K+0.7% | $150K0.0% | ||
| —— | —— | —— | —— | -$54K-58.8% | ||
| $499K+126% | -$1.91M-476% | -$331K-150% | $666K+576% | -$140K-122% | ||
| -$37.06M-19.3% | -$31.06M+17.7% | -$37.73M-1.2% | -$37.27M+1.1% | -$37.69M+14.6% | ||
| $925K+8.8% | $850K-0.7% | $856K-14.9% | $1.01M-8.5% | $1.1M-19.5% | ||
| $30.09M+11.1% | $27.08M-5.3% | $28.59M-13.2% | $32.96M+7.5% | $30.67M-12.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $495K+11.2% | $445K+745% | -$69K+11.5% | -$78K0.0% | -$78K— | ||
| $32K+6.7% | $30K+7.1% | $28K-3.4% | $29K-9.4% | $32K-8.6% | ||
| $19.94M-0.7% | $20.07M— | —— | —— | —— | ||
| —— | —— | —— | —— | -$3.45M+52.7% | ||
| $1.32M+71.2% | $770K+283% | $201K+328% | $47K+9.3% | $43K+7.5% | ||
| -$450K-28.2% | -$351K-37.6% | -$255K-1,600% | -$15K-103% | $492K-52.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $180K+154% | -$334K— | —— | —— | —— | ||
| $908K-20.6% | $1.14M— | —— | —— | —— | ||
| —— | $1.22M+1.1% | $1.21M+1.1% | $1.19M+1.1% | $1.18M+1.1% | ||
| —— | —— | $1.22M+4.5% | $1.17M0.0% | $1.17M0.0% | ||
| —— | —— | —— | —— | -$54K-58.8% | ||
| $38.75M-2.5% | $39.75M-5.9% | $42.25M-12.6% | $48.36M-21.5% | $61.62M-10.8% | ||
| —— | —— | —— | —— | $2.97M-25.0% | ||
| $32K+6.7% | $30K+7.1% | $28K-3.4% | $29K-9.4% | $32K-8.6% | ||
| $311K-36.7% | $491K+1.2% | $485K+12.8% | $430K+41.9% | $303K+4,229% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $499K+126% | -$1.91M-476% | -$331K-150% | $666K+576% | -$140K-122% | ||
| —— | $317K+33.3% | $237.75K+50.0% | $158.5K+100% | $79.25K— | ||
| -$37.98M-19.0% | -$31.91M+17.3% | -$38.58M-0.8% | -$38.28M+1.3% | -$38.79M+14.8% | ||
| -$37.98M-19.0% | -$31.91M+17.3% | -$38.58M-0.8% | -$38.28M+1.3% | -$38.79M+14.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rapid Micro Biosystems generate?
- Rapid Micro Biosystems (RPID) generated -$37.1M in operating cash flow over the trailing twelve months.
- What is Rapid Micro Biosystems's free cash flow?
- After $925.0K of capital expenditures, Rapid Micro Biosystems's free cash flow was -$38.0M over the trailing twelve months, up 2.1% year over year.
- Where does Rapid Micro Biosystems's cash flow data come from?
- Every line is extracted from Rapid Micro Biosystems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
